New fish health role for ex-Benchmark executive

Fish probiotics and vaccines company Previwo has appointed former Benchmark global market development leader Carolina Faune as director of market development.

Previwo, which makes the in-water probiotic Stembiont, said Bergen-based Faune will lead the company’s expansion to new markets as well as strengthening cooperation with customers and key stakeholders in Norway and other existing markets.

Faune is a veterinarian with an MBA from Universidad Austral de Chile and brings more than 20 years of experience working in the aquaculture industry. She has previously held key global roles at pharma companies Novartis and Elanco.

Sustainable solutions

“I am thrilled for the opportunity to join Previwo and I am already impressed by Previwo’s team in Norway,” said Faune in a press release.

“As a veterinarian I am passionate about finding innovative ways to improve the health of our fish populations, a mission which is central to Previwo. We share the principles of bringing sustainable solutions and the long-term view through investing on our people and pipeline together with our customers and key stakeholders.”

Previwo chief executive Kira Salonius said: “We are confident that Carolina, with her background and international roles, will add valuable competence to the scale-up of the company in this key phase.

“With our innovative microbial solutions available in Norway and existing markets in Faroes and Iceland, together with market expansion plans in Chile, Canada, UK and EU, we are well positioned to contribute conferred health benefits to farmed fish globally.”